NovaBay Pharmaceuticals, Inc.
NBY
$0.585
$0.000.00%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 23.53% | 50.68% | 21.76% | -133.81% |
| Total Depreciation and Amortization | 0.00% | -46.93% | 1,391.67% | -87.37% | 0.00% |
| Total Amortization of Deferred Charges | -97.93% | -53.38% | -25.06% | -27.32% | -13.75% |
| Total Other Non-Cash Items | -495.45% | -92.33% | -69.85% | -59.25% | 212.30% |
| Change in Net Operating Assets | 120.61% | -583.04% | 303.51% | -80.34% | 358.93% |
| Cash from Operations | 52.84% | -256.57% | 67.49% | -117.89% | -124.18% |
| Capital Expenditure | 100.00% | 0.00% | 0.00% | 33.33% | -200.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -100.00% | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 0.00% | -100.19% | 35,700.00% | -200.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -27.01% | -7.61% | 17.90% | -22.01% |
| Issuance of Common Stock | -100.00% | 1,173.89% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -405.26% | -116.81% | -- |
| Cash from Financing | -76.07% | 524.59% | 17.59% | -2,196.15% | 95.49% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | 313.00% |
| Net Change in Cash | -1,430.77% | 102.43% | 17.98% | -412.55% | 79.08% |